IFP Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

IFP Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-140	Closed	-$2K	–	3794
2018 Q4	$2K	Buy	+140	New	+$3.08K	﹤0.01%	3239

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

EWM

Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IFP Advisors's AVEO Position: Q1 2019 in Review

IFP Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 77 shares — an estimated $1K sold.

IFP Advisors first reported a position in AVEO in Q3 2017 and held it in 6 quarters. The position peaked at $14K in Q3 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

IFP Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
IFP Advisors sold 77 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1K.
IFP Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2017 and held it in 6 quarters.
IFP Advisors's AVEO Pharmaceuticals, Inc. position peaked at $14K in Q3 2018.
83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.